We are live on ! Find out more
DLA

Douglas Lane & Associates Portfolio holdings

AUM $7.37B
1-Year Est. Return 21.9%
This Fund
S&P 500
This Quarter Est. Return
+0.29%
1 Year Est. Return
+21.9%
3 Year Est. Return
+71.89%
5 Year Est. Return
+87.03%
10 Year Est. Return
+444.88%
AUM
$7.09B
AUM Growth
-$185M
Cap. Flow
-$52.8M
Cap. Flow %
-0.74%
Top 10 Hldgs %
23.26%
Holding
241
New
3
Increased
87
Reduced
126
Closed
7

Top Sells

Rank Stock Value
1
CVS icon
CVS Health
CVS
+$25.9M
2
PRU icon
Prudential Financial
PRU
+$20.7M
3
NVDA icon
NVIDIA
NVDA
+$19.7M
4
GSK icon
GSK
GSK
+$19.6M
5
DEO icon
Diageo
DEO
+$11.5M

Sector Composition

Rank Sector Weight
1 Financials 18.79%
2 Technology 17.98%
3 Industrials 13%
4 Healthcare 12.6%
5 Communication Services 7.96%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NVDA icon
1
NVIDIA
NVDA
$4.72T
$272M 3.84%
2,028,051
-142,753
-7% -$19.7M
JPM icon
2
JPMorgan Chase
JPM
$933B
$183M 2.58%
764,012
-27,933
-4% -$6.51M
GOOG icon
3
Alphabet (Google) Class C
GOOG
$4.08T
$177M 2.49%
928,344
-1,389
-0.1% -$245K
QCOM icon
4
Qualcomm
QCOM
$160B
$170M 2.4%
1,105,552
-27,696
-2% -$4.53M
MSFT icon
5
Microsoft
MSFT
$3.35T
$164M 2.32%
389,662
-10,869
-3% -$4.63M
GDDY icon
6
GoDaddy
GDDY
$13.2B
$158M 2.22%
798,203
-54,358
-6% -$9.93M
AXP icon
7
American Express
AXP
$228B
$147M 2.07%
494,431
-38,255
-7% -$11M
DAL icon
8
Delta Air Lines
DAL
$58.3B
$130M 1.83%
2,142,462
-98,909
-4% -$5.84M
V icon
9
Visa
V
$673B
$127M 1.8%
402,813
-5,921
-1% -$1.78M
BX icon
10
Blackstone
BX
$102B
$122M 1.72%
707,350
-33,135
-4% -$5.77M
MS icon
11
Morgan Stanley
MS
$330B
$122M 1.72%
968,815
-31,327
-3% -$3.86M
RGA icon
12
Reinsurance Group of America
RGA
$15.6B
$121M 1.71%
566,026
-6,687
-1% -$1.46M
MA icon
13
Mastercard
MA
$510B
$111M 1.56%
209,853
-5,378
-2% -$2.78M
TDG icon
14
TransDigm Group
TDG
$69.9B
$104M 1.46%
81,867
-478
-0.6% -$630K
GE icon
15
GE Aerospace
GE
$368B
$98.9M 1.4%
593,133
-28,471
-5% -$5.08M
BAC icon
16
Bank of America
BAC
$433B
$97.1M 1.37%
2,208,470
-137,543
-6% -$6.05M
BMY icon
17
Bristol-Myers Squibb
BMY
$132B
$97M 1.37%
1,714,269
-84,824
-5% -$4.74M
TMO icon
18
Thermo Fisher Scientific
TMO
$214B
$94.9M 1.34%
182,511
+3,460
+2% +$1.9M
ORCL icon
19
Oracle
ORCL
$367B
$94.4M 1.33%
566,388
-16,900
-3% -$3M
EQIX icon
20
Equinix
EQIX
$103B
$91.6M 1.29%
97,141
-275
-0.3% -$253K
JNJ icon
21
Johnson & Johnson
JNJ
$617B
$86.7M 1.22%
599,386
+6,526
+1% +$1.01M
CMCSA icon
22
Comcast
CMCSA
$84B
$83.1M 1.17%
2,213,275
+2,806
+0.1% +$116K
HLN icon
23
Haleon
HLN
$44.5B
$82.3M 1.16%
8,624,149
+161,865
+2% +$1.58M
IR icon
24
Ingersoll Rand
IR
$33B
$79.8M 1.13%
882,126
-30,277
-3% -$3.01M
AMT icon
25
American Tower
AMT
$81.3B
$79.1M 1.12%
431,261
+21,084
+5% +$4.37M

Similar funds

Douglas Lane & Associates's Q4 2024 Portfolio in Review

As of Q4 2024, Douglas Lane & Associates held 241 positions worth $7.09B, down 2.5% from $7.28B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Trading was light in Q4 2024: portfolio turnover was 4.1%. Douglas Lane & Associates opened 3 new positions and exited 7, leaving the 241-position portfolio largely intact.

By sector, the portfolio is most concentrated in Financials at 19% of assets, up from 18% a quarter earlier, followed by Technology and Industrials.

  • Douglas Lane & Associates's largest Q4 2024 buy was CoStar Group: 383,384 shares worth $27.4M.
  • Douglas Lane & Associates added most to WillScot Mobile Mini Holdings in Q4 2024, an estimated $29M increase.
  • Douglas Lane & Associates's biggest Q4 2024 reduction was CVS Health, cutting an estimated $25.9M.
  • Douglas Lane & Associates fully exited Exact Sciences in Q4 2024, selling an estimated $409K.
  • Douglas Lane & Associates's ten largest holdings make up 23% of its $7.09B portfolio in Q4 2024.
  • Douglas Lane & Associates opened 3 new positions and closed 7 in Q4 2024.
  • Douglas Lane & Associates's portfolio value fell 2.5% quarter-over-quarter to $7.09B.

Based on Douglas Lane & Associates's 13F filing for Q4 2024, filed 8 Jan 2025.